{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:06:08Z","timestamp":1713258368549},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hyperhomocysteinemia is caused by genetic and environmental factors, which can result in systemic arteriosclerosis and arteriovenous thrombosis including acute coronary syndrome. Thrombus burden in patients with acute coronary syndrome and hyperhomocysteinemia might involve the culprit lesion as compared with those without any coagulopathy. The primary percutaneous coronary intervention with stent implantation had been established as the treatment strategy for patients with acute coronary syndrome. However, in patients with acute coronary syndrome with high thrombus burden or uncontrolled coagulopathy, stent implantation might lead to slow-flow phenomenon or stent thrombosis. Therefore, the treatment strategy in these patients was not established.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 49-year-old Japanese man with history of splenic infarction of unknown cause had continued anticoagulant therapy since its diagnosis, but stopped taking the medication several months ago. He presented with sudden-onset chest dorsalgia. Contrast computed tomography showed a small pulmonary embolism and his troponin I level was elevated on initial laboratory test. Coronary angiography revealed a contrast defect caused by a large thrombus from the proximal to mid portion of the left anterior descending artery. Near-infrared spectroscopy\u2013intravascular ultrasonography showed a large amount of thrombus without lipid plaque. Therefore, revascularization was performed using a thrombus-aspiration catheter and intracoronary thrombolysis. In addition, , hyperhomocysteinemia and a deep vein thrombosis occurred. He was diagnosed with acute coronary syndrome complicated with pulmonary embolism and deep vein thrombosis simultaneously induced by hyperhomocysteinemia. After 1 week of antithrombotic therapy, near-infrared spectroscopy\u2013intravascular ultrasonography and optical coherence tomography revealed a decreased thrombus and no significant residual organic stenosis in the left anterior descending artery. He continued conservative therapy with antithrombotic medications including aspirin and warfarin and had no cardiovascular events after discharge. Follow-up coronary angiography and optical coherence tomography at 9\u2009months revealed complete disappearance of the thrombus and no severe stenosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Hyperhomocysteinemia should be considered as a cause of arterial vein thrombosis of unknown cause. The antithrombotic therapy and percutaneous revascularization without stenting based on intravascular imaging might be a safe and effective treatment option in patients with acute coronary syndrome complicated with hyperhomocysteinemia.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-020-02531-5","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:21:59Z","timestamp":1604881319000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute coronary syndrome with large thrombus successfully managed with no-stenting revascularization based on intravascular imaging in a patient with hyperhomocysteinemia: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Keisuke","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Wakana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Shirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoaki","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF02983714","volume":"161","author":"R Clarke","year":"1992","unstructured":"Clarke R, Fitzgerald D, O\u2019Brien C, O\u2019Farrell C, Roche G, Parker RA, et al. Hyperhomocysteinaemia: a risk factor for extracranial carotid artery atherosclerosis. Ir J Med Sci. 1992;161:61\u20135.","journal-title":"Ir J Med Sci"},{"key":"2531_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0950-821X(05)80255-5","volume":"7","author":"C Bergmark","year":"1993","unstructured":"Bergmark C, Mansoor MA, Swedenborg J, de Faire U, Svardal AM, Ueland PM. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50\u2013effect of smoking and extent of disease. Eur J Vasc Surg. 1993;7:391\u20136.","journal-title":"Eur J Vasc Surg"},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M den Heijer","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759\u201362.","journal-title":"N Engl J Med"},{"key":"2531_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e) ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877\u201381.","journal-title":"JAMA."},{"key":"2531_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2007.09.029","volume":"198","author":"R Cui","year":"2008","unstructured":"Cui R, Moriyama Y, Koike KA, Date C, Kikuchi S, Tamakoshi A, et al. Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis. 2008;198:412\u20138.","journal-title":"Atherosclerosis."},{"key":"2531_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1053\/euhj.1999.1914","volume":"21","author":"J Thambyrajah","year":"2000","unstructured":"Thambyrajah J, Townend JN. Homocysteine and atherothrombosis--mechanisms for injury. Eur Heart J. 2000;21:967\u201374.","journal-title":"Eur Heart J"},{"key":"2531_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/01.CIR.101.4.372","volume":"101","author":"MK Al-Obaidi","year":"2000","unstructured":"Al-Obaidi MK, Philippou H, Stubbs PJ, Adami A, Rajiv Amersey R, Noble MM, et al. Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation. 2000;101:372\u20137.","journal-title":"Circulation"},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3949\/ccjm.71.9.729","volume":"71","author":"SR Lentz","year":"2004","unstructured":"Lentz SR, Haynes WG. Homocysteine: Is it a clinically important cardiovascular risk factor? Cleve Clin J Med. 2004;71:729\u201334.","journal-title":"Cleve Clin J Med"},{"key":"2531_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","volume":"109","author":"M den Heijer","year":"2007","unstructured":"den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood. 2007;109:139\u201344.","journal-title":"Blood"},{"key":"2531_CR10","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"KH B\u00f8naa","year":"2006","unstructured":"B\u00f8naa KH, Nj\u00f8lstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578\u201388.","journal-title":"N Engl J Med"},{"key":"2531_CR11","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567\u201377.","journal-title":"N Engl J Med"},{"key":"2531_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jcin.2013.04.012","volume":"6","author":"RD Madder","year":"2013","unstructured":"Madder RD, Goldstein JA, Madden SP, Puri R, Wolski K, Hendricks M, et al. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2013;6:838\u201346.","journal-title":"JACC Cardiovasc Interv"},{"key":"2531_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa0706416","volume":"358","author":"T Svilaas","year":"2008","unstructured":"Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557\u201367.","journal-title":"N Engl J Med"},{"key":"2531_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(08)60833-8","volume":"371","author":"PJ Vlaar","year":"2008","unstructured":"Vlaar PJ, Svilaas T, van der Horst IC, Diercks GF, Fokkema ML, de Smet BJ, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371:1915\u201320.","journal-title":"Lancet"},{"key":"2531_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/CIRCINTERVENTIONS.110.959791","volume":"4","author":"SY Choi","year":"2011","unstructured":"Choi SY, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv. 2011;4:239\u201347.","journal-title":"Circ Cardiovasc Interv"},{"key":"2531_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-9560-7-5","volume":"7","author":"A Melhem","year":"2009","unstructured":"Melhem A, Desai A, Hofmann MA. Acute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemia. Thromb J. 2009;7:5.","journal-title":"Thromb J"},{"key":"2531_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2169\/internalmedicine.55.4565","volume":"55","author":"MY Ren","year":"2016","unstructured":"Ren MY, Zhang CS, Zhang XJ, Zhong JQ. Acute myocardial infarction in a young man with hyperhomocysteinemia and pulmonary tuberculosis. Intern Med. 2016;55:153\u20139.","journal-title":"Intern Med"},{"key":"2531_CR18","first-page":"39","volume":"5","author":"S Gokay","year":"2013","unstructured":"Gokay S, Ci\u00e7ek D, M\u00fcderriso\u011flu H. Hyperhomocysteinemia in a young woman presenting with acute myocardial infarction: Case report. Interv Med Appl Sci. 2013;5:39\u201342.","journal-title":"Interv Med Appl Sci"},{"key":"2531_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/1995-705X.152998","volume":"16","author":"WA Shamkani","year":"2015","unstructured":"Shamkani WA, Jafar NS, Narayanan SR, Rajappan AK. Acute myocardial infarction in a young lady due to vitamin B12 deficiency induced hyperhomocysteinemia. Heart Views. 2015;16:25\u20139.","journal-title":"Heart Views"},{"key":"2531_CR20","doi-asserted-by":"publisher","unstructured":"Ukachukwu V, Idris S, McIlwee A. Acute myocardial infarction in a young patient with hyperhomocysteinaemia. BMJ Case Rep. 2012; \nhttps:\/\/doi.org\/10.1136\/bcr-2012-007489\n\n.","DOI":"10.1136\/bcr-2012-007489"},{"key":"2531_CR21","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/hrt.2008.144246","volume":"94","author":"L Politi","year":"2008","unstructured":"Politi L, Monopoli DE, Modena MG. ST-segment elevation myocardial infarction with concomitant multiple coronary arteries thromboses in a young patient with hyperhomocysteinaemia. Heart. 2008;94:1180. \nhttps:\/\/doi.org\/10.1136\/hrt.2008.144246\n\n.","journal-title":"Heart."},{"key":"2531_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/eurheartj\/ehx504.P4563","volume":"38","author":"H Jia","year":"2017","unstructured":"Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, et al. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J. 2017;38:792\u2013800.","journal-title":"Eur Heart J"},{"key":"2531_CR23","doi-asserted-by":"publisher","unstructured":"EROSION study (effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion): a1-year follow-up report. Circ Cardiovasc Interv. 2017;10(12):e005860. \nhttps:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005860\n\n. PMID: 29246916.","DOI":"10.1161\/CIRCINTERVENTIONS.117.005860"},{"key":"2531_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/2048872615617044","volume":"6","author":"R Meyer-Saraei","year":"2017","unstructured":"Meyer-Saraei R, de Waha S, Eitel I, Desch S, Scheller B, B\u00f6hm M, et al. Thrombus aspiration in non-ST-elevation myocardial infarction - 12-month clinical outcome of the randomised TATORT-NSTEMI trial. Eur Heart J Acute Cardiovasc Care. 2017;6:10\u20137.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2531_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","volume":"372","author":"SS Jolly","year":"2015","unstructured":"Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015;372:1389\u201398.","journal-title":"N Engl J Med"},{"key":"2531_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/01.CIR.86.1.131","volume":"86","author":"FW Bar","year":"1992","unstructured":"Bar FW, Verheugt FW, Col J, Materne P, Monassier JP, Geslin PG, et al. Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation. 1992;86:131\u20137.","journal-title":"Circulation."},{"key":"2531_CR27","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","volume":"89","author":"The Thrombolysis in Myocardial Ischemia (TIMI) III B investigators","year":"1994","unstructured":"The Thrombolysis in Myocardial Ischemia (TIMI) III B investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction. Results of TIMI IIIB Trial. Circulation. 1994;89:1545\u201356.","journal-title":"Circulation"},{"key":"2531_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MCA.0000000000000614","volume":"29","author":"T Sugiyama","year":"2018","unstructured":"Sugiyama T, Xing L, Yamamoto E, Fracassi F, Lee H, Yu B, et al. Thrombus resolution with tirofiban in the conservative management of patients presenting with plaque erosion. Coron Artery Dis. 2018;29:301\u20138.","journal-title":"Coron Artery Dis"},{"key":"2531_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1253\/circj.CJ-08-0560","volume":"73","author":"Y Nakagawa","year":"2009","unstructured":"Nakagawa Y, Nobuyoshi M, Yamaguchi T, Meguro T, Yokoi H, Kimura T, et al. Efficacy of abciximab for patients undergoing balloon angioplasty data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT). Circ J. 2009;73:145\u201351.","journal-title":"Circ J"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-020-02531-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:24:35Z","timestamp":1604881475000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02531-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02531-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or with comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images and videos. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}